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Single variant analysis in genome-wide association studies (GWAS) has been proven to
be successful in identifying thousands of genetic variants associated with hundreds of
complex diseases. However, these identified variants only explain a small fraction of
inheritable variability in many diseases, suggesting that other resources, such as multilevel
genetic variations, may contribute to disease susceptibility. In this work, we proposed to
combine genetic variants that belong to a gene set, such as at gene- and pathway-level
to form an integrated signal aimed to identify major players that function in a coordinated
manner conferring disease risk. The integrated analysis provides novel insight into disease
etiology while individual signals could be easily missed by single variant analysis. We
applied our approach to a genome-wide association study of type 2 diabetes (T2D) with
male and female data analyzed separately. Novel sex-specific genes and pathways were
identified to increase the risk of T2D. We also demonstrated the performance of signal
integration through simulation studies.
Keywords: p-value combination, gene-based analysis, pathway-based analysis, sex-specific analysis, type 2
diabetes
1. INTRODUCTION
Advancements in microarray and next generation sequencing
technologies enable people to find more and more genetic
variants, including small variations in single nucleotide poly-
morphisms (SNPs) and large variations, such as indel and copy
number variation. Genome-wide association studies (GWAS),
which focus on the association between SNPs and complex dis-
eases, have been proven to be a powerful tool to unveil the genetic
secret of complex diseases. However, the identified SNPs can
only account for a small fraction of heritability in many diseases,
motivating people to develop more advanced statistical methods
and novel models with the hope to find the missing heritability.
Among the large efforts being pursued, it is natural to consider
gene-set or pathway-based analysis given that genes in a path-
way or network tend to work coordinately to fulfill their tasks.
The subtle effects in multiple SNPs can be combined so that the
joint signal in a gene set could be potentially boosted. A variety
of public resources are available to create the gene-set, such as
Kyoto Encyclopedia of Genes and Genomes (KEGG) (Kanehisa,
2000), Reactome (Joshi-Tope et al., 2005) and Gene Ontology
(Ashburner et al., 2000). Signal-based combinationmethods have
been broadly applied in this context and can be classified into
two categories: the one-step approach and the two-step approach.
The former one treats all SNPs equally and combines effects of all
SNPs within a certain pathway to come up with a total signal. The
latter one firstly obtains a gene-score by combining SNP effects in
a gene, then constructs a higher hierarchical test statistic to score
a gene-set (or pathway) using the previously achieved gene scores.
In either case, the significance of a bigger set (e.g., a pathway) is
evaluated using either asymptotic approach, or more practically,
permutation techniques. However, the one-step approach might
lose power since the association signals are equally considered in
different genes without considering the hierarchical structure of a
gene set.
Toward the signal integration, p-value combination is a pop-
ular one since p-value possesses several nice characteristics such
as model-free, clear interpretation and standard scale. Different
p-value combination methods were widely discussed in the liter-
ature, such as Fisher’s method that summarizes signals using a
transformation of the p-value product as the test statistic (Fisher,
1932), the truncated product (TP) method which considers the
product of p-values less than a pre-defined threshold (Zaykin
et al., 2002), the rank truncated product (RTP) method which
employs top R most significant p-values with R being the pre-
selected rank truncation threshold (Zaykin et al., 2006), and the
adaptive rank truncation product (ARTP) method where the
rank truncation point is adaptively selected from T truncation
candidates R1, · · · ,RT to optimize the permutation p-value of
the test statistic (Hoh et al., 2001; Dudbridge and Koeleman,
2004). Furthermore, p-value combination can be applied either
in one-step combination or two-step combination. Although the
one-step ARTP method (e.g., Hoh et al., 2001; Dudbridge and
Koeleman, 2004) is more flexible to the choices of the truncation
point compared to other one-step truncationmethods, it uses one
single threshold for all the genes in a pathway, disregarding of
their individual sizes and linkage disequilibrium (LD) structures,
hence may not be reasonable in practice. In fact, an overesti-
mated truncation might dilute the signal, while underestimation
www.frontiersin.org November 2014 | Volume 5 | Article 395 | 1
He et al. Pathway-based association analysis in T2D
will lead to major signal loss. To overcome the limitation of the
one-step analysis, a two-step ARTP model was developed Yu et al.
(2009). However, there is no unified criterion for the choice of
T. In addition, as a permutation-based method, ARTP is compu-
tationally expensive to achieve a small p-value, and this burden
could be much heavier when T is chosen to be large.
These limitations motivate us to consider a two-step anal-
ysis while maintaining the hierarchical genetic structure in a
gene set. Li et al. (2011) proposed a one-step p-value combina-
tion approach to infer pathway regulations in an eQTL mapping
framework. By introducing the hierarchical pathway structure, we
extend thismethod to a two-step one under the GWAS framework
and name it as scaled chi-square combination (SCC) method. We
propose to combine individual SNP p-values in a lower genetic
system (e.g., a gene) in the first step, then summarize the gene
signals in a higher system (e.g., a pathway) in the second step,
while considering the correlations among genetic variants in the
SNP- and gene-level. This joint analysis could spark additional
insights into pathway function on a disease trait that otherwise
could be missed by looking at individual signals alone. Another
advantage using SCC method is that there is no need for trunca-
tion, which also implies no information dropping. Besides, since
p-value is derived based on a chi-square approximation, small
p-values can be obtained which cannot be easily achieved by
permutation-based methods.
Examples of other two-step methods also include gene set scan
(GSS) (Schaid et al., 2012) and modified gene set enrichment
analysis (MGSEA) (Wang et al., 2007). In GSS, each gene is firstly
scored using average SNP signals, which are individually evalu-
ated via a score statistics from a regressionmodel. Then a pathway
signal is scored by the weighted “average” signals from genes, and
a normal distribution is assumed to compute the p-value of a
pathway. While in MGSEA, the smallest p-value among all SNPs
in a gene is chosen to represent the gene signal. Pathways are then
scored using weighted Kolmogorov-Smirnov like running sum
statistic, and the significance of a pathway is evaluated based on
permutation approach. Obviously the GSS method is limited by
taking average when large number of noisy SNPs are present.
The article begins with a detailed description of using Fisher’s
combination statistic to score genes and pathways, and the
Satterthwaite approximation of the null distribution of the com-
bined p-values. Section 3 provides real data analysis on two type 2
diabetes (T2D) cohorts data sets. In section 4 we demonstrate the
utility of SCC via extensive simulations and compare it to other
two-step methods (e.g., ARTP and MGESA) under a variety of
scenarios, followed by the discussion in section 5.
2. STATISTICAL METHODS
2.1. COMBINING AND APPROXIMATING
Assume L tests are conducted for the association between a disease
trait and L SNPs in a given genetic system, and let p1, p2, · · · , pL
be the p-values for the L individual tests. For example, if we
want to test whether a gene (consisting L SNPs) is associated
with a disease trait, the gene would be the system and individ-
ual SNP is the unit; pathway and gene would be the system and
unit respectively when testing the association between a disease
trait and a pathway containing L genes. Define Wi = −2 log pi.
Under the null hypothesis of no genetic effect, each of the L p-
values is uniformly distributed and Wi ∼ χ22 for i = 1, · · · , L.
If we assume the L tests are independent, the Fisher’s combined
statistic Z =∑Li= 1 Wi ∼ χ22L under the global null hypothesis of
no genetic effect in the genetic system.
Since units in a genetic system tend to work coordinately,
they are more or less correlated. Hence the L p-values are not
independent and the chi-square distribution with 2L degrees of
freedom (df ) in Fisher’s method may not be true. To adaptively
account for the combined effect of L correlated χ22 distribu-
tions, Satterthwaite’s approximation can be introduced, where a
scaled chi-square distribution is used to approximate the null
distribution of Z, i.e.,
Z =
L∑
i= 1
Wi∼˙aχ2d , (1)
and the scale parameter a and the df parameter d are chosen by
equating the first and second moments of the scaled chi-square
distribution with the ones of Z under the null hypothesis, respec-
tively. Under the independence case, the means and variances of
the statistic Z under the null are
E(Z) = E
(
L∑
i= 1
Wi
)
= 2L,
Var(Z) = 4L + 8
∑
i< j
ρij,
where ρij = Cov(Wi,Wj) is the correlation coefficient between
the log-transformed p-values Wi and Wj. Solving the moment
equations E(Z)=˙E(aχ2d ) = ad and Var(Z)=˙Var(aχ2d ) = 2a2d, we
have
aˆ = 1 + 2
∑
i< j ρij
L
, dˆ = 2L
2
L + 2∑i< j ρij , (2)
When the L units in a genetic system are completely indepen-
dent, i.e., ρij = 0 for all i = j, the Satterthwaite’s approximation
(aˆ = 1, dˆ = 2L) is exactly the same as the distribution of the
Fisher’s combined statistic which assumes independence. When
the L units are perfectly dependent in the meaning of ρij = 1 for
all i = j, the approximation degenerates to aˆ = L, dˆ = 2. Beyond
these extreme cases, the scaled chi-square approximation has
much flexibility to account for the correlation structure among
the units.
2.2. GENE SET SCORING
In the following we describe how to score genetic unit in each
level. Assume the pathway of interest consists of K genes, where
the kth gene consisting nk SNPs (1 ≤ k ≤ K) and (pk1, · · · , pknk)
are p-values of those SNPs. Let k be the correlation matrix of
the transformed p-value vector wk = (wk1, · · · ,wknk), which rep-
resents the correlation structure among the nk SNPs within the
kth gene. For each gene, a combined score z
gene
k =
∑nk
m= 1 wkm
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could be obtained. Together with the shape parameter (aˆk, dˆk)
estimated in (2), a gene-based p-value
p
gene
k = P
(
z
gene
k > sˆkχ
2
dˆk
)
, 1 ≤ k ≤ K
can be obtained. This finishes the signal combination of the first
step.
Let wgene = (wgene1 , · · · ,wgeneK ) be the -2log transformed p-
value vector for the K genes obtained in the first step, and  is the
corresponding correlationmatrix. In the second step, the pathway
can be scored as zpath =∑Km= 1 wgenem and the shape parameters
(aˆ2, dˆ2) can be estimated in a similar way. Then a p-value of
the pathway, which reflects its association strength with a disease
trait, can be obtained by ppath = P
(
zpath > aˆ2χ2
dˆ2
)
. The problem
remaining is to estimate the correlation matrices among L SNPs
as well as among K genes, which is discussed in the next section.
2.3. ESTIMATING CORRELATION MATRIX
A permutation (or resampling) procedure is applied here to esti-
mate the correlation matrix of a transformed p-value vector on a
gene- or pathway-level. We first obtain the L dimensional trans-
formed p-value vector w(0) = {w(0)1 , · · · ,w(0)L } through single-
SNP testing based on the original data. Then we generate B
datasets under the null hypothesis of no association between the
SNPs and trait, by simply permuting the trait label while keep-
ing the genotype fixed such that the correlation structure among
SNPs/genes is not disrupted. Through each of the permuting pro-
cess, we could obtain a new transformed p-value vector w(b) (b =
1, · · · ,B). Then the correlation matrices k, k = 1 · · · ,K and 
can be estimated using the sample correlation matrices from the
permuted data. Note that only one single layer of permutations
is needed, and moderate permutations are needed to estimate
the correlations in k, k = 1 · · · ,K and . Typically B = 200 is
enough to obtain reasonable estimation of the correlation mat-
ices, compared to large number of permutations to obtain small
p-values as implemented in the ARTP procedure.
3. RESULTS
3.1. REAL DATA ANALYSIS
A growing number of experimental evidence shows that there
is gender effect related to type 2 diabetes (T2D). For instance,
individual SNP test results indicate moderately differential sig-
nals between male and female population (Wu and Cui, 2013),
and there also exists sex difference in the impact of T2D on
coronary heart disease risk (Juutilainen et al., 2004). Therefore,
we are specifically interested in identifying sex-specific pathways
associated with T2D with the hope to gain novel insight into
the disease etiology of T2D in different sex groups. We applied
four different two-step methods including SCC, ARTP, MGSEA
and GSS to two nested case-control cohort T2D datasets, the
Nurses’ Healthy Study (NHS) and the Health Professional Fellow-
up Study (HPFS), which are part of the Gene, Environment
Association Studies (GENVEA) (Cornelis et al., 2010). Please
refer to Hu et al. (2001) and van Dam (2002) for more detailed
information about the datasets. The raw datasets originally
include 3391 female and 2599 male participants with European
ancestry, respectively. Individuals with large proportion of miss-
ing SNPs (>10%) or large kinship relationship with others were
removed. We also removed SNPs with minor allele frequency
(MAF) <0.05 or deviation from Hardy-Weinberg equilibrium
(p< 0.001) in controls. The final data set contains 672,105 SNPs
in 3371 females (1572 cases and 1799 controls) and 671,669 SNPs
in 2494 males (1161 cases and 1333 controls). SNPs that are
within 50 kb up- and down-stream of a gene were assigned to the
corresponding gene based onHumanGenome Build 37.3 . Totally
186 KEGG pathways was retrieved from the Molecular Signatures
Database (MSigDB) covering 5015 genes using the Gene Set
Enrichment Analysis package (Subramanian et al., 2005). The
final data set contains 143,137 SNPs in female and 143,272 SNPs
in male.
We conducted separated analysis in the two gender groups, in
each of which SNP signals were combined together in two steps to
represent the overall contribution of the pathway. Seven covari-
ates (p-value< 0.05) was included into the model, including
family history of diabetes among first degree relatives, reported
high blood pressure at/before blood draw, reported high blood
cholesterol at/before blood draw, total physical activity, body
mass index, heme iron intake and glycemic load, to adjust for
the covariates’ effect when fitting a logistic regression model to
test individual SNP effect. An additive gene action model was
assumed when coding the SNP effect. The obtained p-values were
then applied to the four methods, SCC, ARTP, MGSEA, and GSS
following the recommended settings of each method.
Figure 1 shows the Manhattan plot of the single SNP signals
across the 22 autosomal chromosomes for the female and male
groups with the vertical axes represent the −log10 p-values. The
dashed line corresponds to the genome-wide Bonferroni thresh-
old. The overall pattern is quite similar in the male and female
population with a few clear differences, especially on chromo-
some 2, 3, 4, 5, 10, and 13. The signals passing the genome-wide
Bonferroni threshold located on chromosome 10 in the male
group are from gene TCF7L2, one of the genes associated with
T2D and being replicated in several GWAS studies (Grant et al.,
2006; Sladek et al., 2007).
Figure 2 shows the KEGG gene signals when combining
SNP signals in a gene. Again the dashed line corresponds
to the genome-wide Bonferroni threshold. Genes passing the
Bonferroni threshold are IL18RAP (on chr2), BST1 (on chr4),
TCF7L2 (on chr10) and PIGQ (on chr16) in the female popula-
tion, and SNRNP200 and DUSP2 (on chr2), MCM3 (on chr6),
ABO (on chr9), TCF7L2 (on chr10) and GYS2 (on chr12) in
the male population. Again we observed gender difference in
association signals at the gene level. It is worthy to note that
although all SNPs in gene TCF7L2 in the female population do
not show significance, the combined gene signal reached the
genome-wide gene-level significance. This shows the power of
signal combination to boost the association signal.
In a short summary, we observed significant gender difference
in association signals at both the SNP and gene level. In addi-
tion, we found that the gene-level signal was more significant
through signal combination. For example, the gene-level signal
on chromosome 2 passed the genome-wide Bonferroni threshold
(∼ 10−5), while the SNP-level p-value failed. Under the scenarios
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FIGURE 1 | Manhattan plot of single SNP p-values. The horizontal dotted line represents the genome-wide significance threshold which is labeled in the
figure.
FIGURE 2 | Manhattan plot of KEGG gene p-values. The horizontal dotted line represents the genome-wide gene-level significance threshold which is
labeled in the figure.
where multiple causal SNPs with moderate or small effects are
not significant individually, the gene-level signal can be poten-
tially boosted through combination. This is one of the major
advantages of using combined method. The top gene-level signals
using the ARTP method with the recommended parameter set-
tings, were partially similar to the results obtained using the SCC
method (see Supplementary Table 1 for details). However, more
permutations are needed to achieve small p-values by using the
ARTP method which imposes more computation burden. Note
that not all SNPs with strong signals in the SNP-level analysis can
be mapped to a gene. Thus, it is not surprise why some locations
have strong SNP signals but weak gene signals.
Table 1 summarizes the significant KEGG pathways in female
and male groups after the FDR control with q-value< 0.05
(Storey and Tibshirani, 2003). Total 13 pathways were enriched in
female group and 5 were enriched in male group, with 3 in com-
mon. There is clear heterogeneity in pathway association between
the two sex groups. Since TCF7L2 belongs to several enriched
pathways (3 in female group, 5 in male group) and is widely rec-
ognized as a gene conferring risk of T2D, we conducted the same
analysis but deleting this gene in all pathways. Figure 3 shows
the pathway-level signals across 186 KEGG pathways with and
without TCF7L2, in female and male groups, respectively, where
the solid line represents the FDR threshold. It can be seen from
Figure 3 that there is no significant change between pathway sig-
nals with and without gene TCF7L2 in female group, while the
strong signals in male group are almost vanished after deleting
the gene. This observation suggests potential difference in T2D
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Table 1 | List of enriched KEGG Pathways in Female and Male
population.
KEGG pathway name No. genes Female Male
KEGG maturity onset diabetes of the
young
25
√
–
KEGG pathways in cancer 315
√
–
KEGG TGF beta signaling pathway 86
√
–
KEGG hedgehog signaling pathway 55
√
–
KEGG type II diabetes mellitus 46
√
–
KEGG melanoma 67
√
–
KEGG sphingolipid metabolism 37
√
–
KEGG type I diabetes mellitus 41
√
–
KEGG MAPK signaling pathway 256
√
–
KEGG one carbon pool by folate 17
√
–
KEGG alpha linolenic acid metabolism 19
√
–
KEGG thyroid cancer* 29 –
√
KEGG arrhythmogenic right ventricular
cardiomyopathy ARVC∗
72 –
√
KEGG adherens junction* 73 –
√
KEGG basal cell carcinoma* 55
√ √
KEGG colorectal cancer*+ 61 √ √
+Pathway signal decreased greatly when TCF7L2 gene was deleted in female.
*Pathway signal decreased greatly when TCF7L2 gene was deleted in male.
FIGURE 3 | Manhattan plot of KEGG pathway p-values. The horizontal
solid line represents the genome-wide pathway level significance threshold
which is labeled in the figure.
etiology in the pathway level in each gender group. The signifi-
cance of the pathways in the male group is largely dominated by
gene TCF7L2.
The other three methods, ARTP, MGSEA, and GSS, all failed
to detect any significant pathways after the FDR control (see
Supplementary Tables 2–4). GSS gives p-values all greater than
0.08 for the 186 pathways. This is not surprising since GSS tends
to lose power due to averaging when large number of noise vari-
ants are included (Schaid et al., 2012). The method could be
benefitted by a SNP pre-selection (Wu and Cui, 2014). It should
be noted that KEGG type II diabetes mellitus pathway, which is
a manually annotated gene set, is only identified using the SCC
method. This indicates the robustness of the SCC method.
4. SIMULATION STUDY
To evaluate the statistical performance of different combi-
nation approaches, extensive Monte Carlo simulations were
conducted. Following the simulation design in Biernacka
et al. (2011), we selected SNPs in KEGG pathway matu-
rity_onset_diabetes_of_the_young which contains 25 genes, to
simulate genotypes, based on a total of 5961 observed individuals.
The 25 genes covering 599 SNPs were first mapped to 14 chro-
mosomes and then phased using software fastPHASE (Scheet and
Stephens, 2006). In each of the simulation replicate, 6000 hap-
lotypes were simulated using the hapsim library in R (Montana,
2005) based on the haplotype frequencies obtained in the first
step. Then pairs of hyplotypes were randomly assigned to 3000
individuals, where the disease status of the ith subject Yi was gen-
erated through a Bernoulli distribution, i.e., Yi ∼ Ber(pi) with
logit(pi|Gi) = α(Gi), and Gi is the genotype vector whose lth
component Gil was coded as 0, 1, or 2 according to the counts
of minor alleles at the lth SNP (1 ≤ l ≤ 599). Based on the 3000
subjects, equal number (m) of cases and controls were randomly
picked to form the case-control data (m = 500, 1000) for each
simulation replicate. The type I error (false positive rate) and
power were evaluated based on the 0.05 significance level and
1000 simulation replicates.
Under the null hypothesis of no genetic association between
phenotype and pathway, we let α(Gi) = 0, i.e., logit(pi) = 0.5,
which leads to case:control=1:1. Under the alternative hypothesis,
three scenarios were considered based on the following model,
α(Gi) = GTi β + GTi Gi, (3)
where β is a vector with β l denoting the marginal effect of the
lth SNP in the pathway, and  is a matrix whose (s, t) entry st
represents the interaction between the sth and tth SNP. The three
scenarios, which were described in Figure 4 with detailed infor-
mation listed in Table 2, correspond to different gene actions.
Scenario A considers the case in which there is only one mod-
erate marginal effect (odds ratio = 1.4) in each of the five genes.
Scenario B assumes there are several small effects (odds ratio =
1.1) in each of the five genes. Scenario C assumes small effects as
well as weak interactions within a gene and between genes. In the
simulation, only five genes out of 25 were assumed to be associ-
ated with the trait. The causal SNPs were fixed in each simulation
replicate. The MAF information of the causal SNPs calculated
from the real data were given in Supplementary Table 5.
Table 3 summarizes the power and the type I error at the gene
level combination using the ARTP and SCC methods. The type I
error for MGSEA was rendered to the pathway level analysis. In
the table, the results obtained with the SCC method are listed in
the parenthesis. The ones with higher power are highlighted with
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FIGURE 4 | Three simulation scenarios. OR, odds ratio; IWG, interactions within a gene; IBG, interactions between genes. β l = logOR for isolated nodes
(SNPs), and st = logOR for any two nodes connected with edge.
Table 2 | List of different simulation scenarios.
Gene Chromosome Gene Gene Scenario Scenario Scenario
name ID size A B C
NR5A2 1 2494 95 M 6S 6S (+I)
GCK 7 2645 21 M 5S 5S (+I)
NEUROG3 10 50674 36 M 6S 6S (+I)
HNF1A 12 6927 29 M 6S 6S (+I)
HNF1B 17 6928 44 M 9S 9S (+I)
S, small effect (OR = 1.1); M, moderate effect (OR = 1.4); +I: with interactions.
bold font. Clearly the type I error rates for all the five genes under
different sample sizes are reasonably controlled by the two meth-
ods. For the power, ARTP method achieves higher power than
SCC does under scenario A, while SCCmethod beats ARTP under
scenarios B and C for most genes. Note that gene NEUROG3
exhibits different pattern compared to other genes (Table 3) in
which ARTP method performs better in Scenario B and C. A
summary of the causal SNP’s MAF (see Supplementary Table 5)
shows that four our of six causal SNPs in this gene have MAF
lower than 0.07. Since low MAF generally leads to low test signal,
the combined signal under Scenario B/C is mainly determined by
the other two SNPs, a case similar to Scenario A where we expect
better performance for truncated method (i.e., ARTP).
Table 4 shows the power and type I error at the pathway
level analysis. The type I error rates are reasonably controlled
in all cases. Compared to SCC, ARTP and MGSEA achieve bet-
ter performance under scenario A. However, under scenario B
and C where the joint effect of several SNPs with small marginal
effect and/or interactions, SCC is more powerful than ARTP
and MGSEA in testing pathway association. Among the three,
MGSEA performs the worst. Although SCC is less powerful than
the other two under small sample size (2m = 1000), it catches
up quickly when sample size increases (2m = 2000). The sim-
ulation results indicate the power gain of the SCC method, in
particular under scenarios C when interactions between SNPs are
present. To further distinguish the pathway-level power difference
under Scenarios A and B with case:control = 1000:1000, as per
one reviewer suggestion, we did more simulation by reducing the
effect size (i.e., OR). Under Scenario A, ARTP has better power
while SCC is quite close to it. Under Scenario B, SCC clearly
dominates the other two (see Supplementary Table 6).
5. DISCUSSION
In this work, we proposed a pathway-based associationmethod by
combining single SNP p-values in two steps to identify pathways
(or gene-sets) associated with a disease trait. Although our model
was applied and simulated based on the binary disease trait, it
can be utilized for other data types such as quantitative or count
trait. The strategy also allows to adjust for the effects of covariates
as well as gene-environment interactions. Comparing to other
signal combination methods, our methods has the following
advantages: (1) Unlike other methods using hard truncation, our
method avoids the risk of throwing any important but marginally
weak signals while accounting for the correlation structure among
the combined signals. For the MGSEA method, a gene signal is
represented by the strongest SNP signal within the gene, thus
it suffers from power loss by dropping important SNP signals.
For GSS, the averaging strategy could lose power when large
number of noise SNPs are presented in a set. Although the perfor-
mance of ARTP might be improved by doing large permutations
(e.g., >10,000), it is computational intensive and furthermore,
there is no unified criterion on the choice of truncation rank
upper bound T. The computational load of ARTP would be fur-
ther enhanced if T is large (e.g., causal SNPs/genes are dense
in gene/pathway); (2) The scaled chi-square approximation can
achieve small p-values which is computationally burdensome for
other permutation based methods such as ARTP. Hence, SCC
is computationally efficient and small p-values can be achieved
without large scale permutations; (3) As revealed by simula-
tion studies (Table 4), SCC exhibits great power than other two
methods when there exist interactions between SNPs in a gene set.
We applied ourmethod to two cohort studies of type 2 diabetes
with pathways defined in KEGG databases. Several sex-specific
patterns were observed. Firstly, both the gene- and pathway-
level scan results showed that there was not much signal overlap
between the female and male population, as also revealed by
applying other tools (e.g., ARTP, MGSEA, and GSS). Secondly,
more pathways were enriched in female population compar-
ing to male population. SCC exhibited greater performance in
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Table 3 | Gene-level simulation results with ARTP and SCC under different scenarios*.
case:control Scenario NR5A2 GCK NEUROG3 HNF1A HNF1B
500:500 ScenarioA 0.688 (0.616) 0.514 (0.461) 0.632 (0.434) 0.731 (0.767) 0.428 (0.325)
ScenarioB 0.820 (0.862) 0.122 (0.141) 0.159 (0.121) 0.692 (0.804) 0.420 (0.650)
ScenarioC 0.505 (0.581) 0.116 (0.169) 0.464 (0.354) 0.172 (0.226) 0.308 (0.519)
Under the null 0.044 (0.053 ) 0.045 (0.056) 0.051 (0.053) 0.048 (0.054) 0.051 (0.062)
1000:1000 ScenarioA 0.966 (0.941) 0.905 (0.833) 0.953 (0.80) 0.976 (0.970) 0.805 (0.633)
ScenarioB 0.990 (0.997) 0.189 (0.238) 0.341 (0.304) 0.954 (0.974) 0.757 (0.943)
ScenarioC 0.836 (0.880) 0.205 (0.288) 0.833 (0.688) 0.276 (0.350) 0.596 (0.828)
Under the null 0.042 (0.060) 0.044 (0.049) 0.061 (0.048) 0.053 (0.065) 0.046 (0.057)
*The results using the SCC method are given in the parenthesis while higher power between the two is highlighted with bold font.
Table 4 | Pathway-level simulation results under three different scenarios.
Method case:control=500:500 case:control=1000:1000
ARTP MGSEA SCC ARTP MGSEA SCC
ScenarioA 0.852 0.754 0.757 1.000 1.000 0.996
ScenarioB 0.755 0.529 0.784 0.994 0.971 0.998
ScenarioC 0.383 0.294 0.489 0.863 0.747 0.905
Under the null 0.051 0.042 0.050 0.045 0.043 0.048
The highest power among the three methods (ARTP, MGSEA and SCC) is highlighted with bold font.
detecting associated pathways, especially for the curated KEGG
T2D pathway type II diabetes mellitus which cannot be detected
by other methods such as ARTP, MGSEA, and GSS. In addition,
gene TCF7L2 in female population also shows significance after
p-value combination, while no single SNP in this gene shows
significance. This clearly demonstrates the power of signal combi-
nation to identify SNPs that function jointly but could be missed
by marginal analysis. We also did the QQ plot of the p-values
(results not shown). The gene-based p-value QQ plots showed
a reasonable pattern at different significance levels. But for the
pathway-based p-value QQ plots, there is a moderate departure
from the expected. This is due to the fact of dependent p-values
sincemany pathways share common genes and the pathway-based
p-values are not completely independent.
Our simulation studies showed reasonable control of false
positive rate of the method, on either gene- or pathway-level
combination. Simulation studies also revealed that the opti-
mal choice of combination methods depends on the underlying
true disease model. As what we expected, under scenario A
where only one SNP with moderate effect functions in each of
the five genes, ARTP and MGSEA were more powerful. This
is because the default T is 1 for SNP-level and 10 for gene-
level in ARTP, and MGSEA only picks the most significant
signal at each level. Under scenario B and C where there exist
several SNPs with small marginal effects and interactions con-
tributing to a disease risk, SCC obtained better performance,
benefitted from no truncation (i.e., no information dropping).
In reality, the true model is generally unknown although sce-
narios B and C are more likely. We suggest users to apply
different methods and pool top signals for further functional
validation.
ACKNOWLEDGMENTS
This work was partially supported by grants from NSF (MCP-
1121650 and DMS-1209112) and from National Natural Science
Foundation of China (31371336). Funding support for the
GWAS of Gene and Environment Initiatives in Type 2 Diabetes
was provided through the NIH Genes, Environment and Health
Initiative [GEI] (U01HG004399). The datasets used for the anal-
yses described in this manuscript were obtained from dbGaP at
http://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_
id=phs000091.v2.p1, through dbGaP accession number
phs000091.v2.p1.
SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found
online at: http://www.frontiersin.org/journal/10.3389/fgene.
2014.00395/abstract
REFERENCES
Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., et al.
(2000). Gene ontology: tool for the unification of biology. The Gene Ontology
Consortium. Nat. Genet. 25, 25–29. doi: 10.1038/75556
Biernacka, J. M., Jenkins, G. D., Wang, L., Moyer, A. M., and Fridley, B. L. (2011).
Use of the gamma method for self-contained gene-set analysis of snp data. Eur.
J. Hum. Genet. 20, 565–571. doi: 10.1038/ejhg.2011.236
Cornelis, M. C., Agrawal, A., Cole, J. W., Hansel, N. N., Barnes, K. C., Beaty, T. H.,
et al. (2010). The gene, environment association studies consortium (geneva):
maximizing the knowledge obtained from gwas by collaboration across studies
of multiple conditions. Genet. Epidemiol. 34, 364–372. doi: 10.1002/gepi.20492
Dudbridge, F., and Koeleman, B. P. (2004). Efficient computation of significance
levels for multiple associations in large studies of correlated data, includ-
ing genomewide association studies. Am. J. Hum. Genet. 75, 424–435. doi:
10.1086/423738
Fisher, R. A. (1932). Statistical Methods for Research Workers. London: Oliver and
Boyd.
www.frontiersin.org November 2014 | Volume 5 | Article 395 | 7
He et al. Pathway-based association analysis in T2D
Grant, S. F., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A.,
Sainz, J., et al. (2006). Variant of transcription factor 7-like 2 (tcf7l2) gene
confers risk of type 2 diabetes. Nat. Genet. 38, 320–323. doi: 10.1038/ng1732
Hoh, J., Wille, A., and Ott, J. (2001). Trimming, weighting, and grouping snps
in human case-control association studies. Genome Res. 11, 2115–2119. doi:
10.1101/gr.204001
Hu, F. B., Manson, J. E., Stampfer, M. J., Colditz, G., Liu, S., Solomon, C. G., et al.
(2001). Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. New
Engl. J. Med. 345, 790–797. doi: 10.1056/NEJMoa010492
Joshi-Tope, G., Gillespie, M., Vastrik, I., D’Eustachio, P., Schmidt, E., de Bono, B.,
et al. (2005). Reactome: a knowledgebase of biological pathways.Nucl. Acids Res.
33(Suppl. 1), D428–D432. doi: 10.1093/nar/gki072
Juutilainen, A., Kortelainen, S., Lehto, S., Rönnemaa, T., Pyörälä, K., and Laakso,
M. (2004). Gender difference in the impact of type 2 diabetes on coronary heart
disease risk. Diabetes Care 27, 2898–2904. doi: 10.2337/diacare.27.12.2898
Kanehisa, M. (2000). Kegg: kyoto encyclopedia of genes and genomes. Nucl. Acids
Res. 28, 27–30. doi: 10.1093/nar/28.1.27
Li, S., Williams, B. L., and Cui, Y. (2011). A combined p-value approach
to infer pathway regulations in eqtl mapping. Stat. Inter. 4, 389–402. doi:
10.4310/SII.2011.v4.n3.a13
Montana, G. (2005). Hapsim: a simulation tool for generating haplotype data
with pre-specified allele frequencies and ld coefficients. Bioinformatics 21,
4309–4311. doi: 10.1093/bioinformatics/bti689
Schaid, D. J., Sinnwell, J. P., Jenkins, G. D., McDonnell, S. K., Ingle, J. N., Kubo,
M., et al. (2012). Using the gene ontology to scan multilevel gene sets for asso-
ciations in genome wide association studies. Genet. Epidemiol. 36, 3–16. doi:
10.1002/gepi.20632
Scheet, P., and Stephens, M. (2006). A fast and flexible statistical model for large-
scale population genotype data: applications to inferring missing genotypes and
haplotypic phase. Am. J. Hum. Genet. 78, 629–644. doi: 10.1086/502802
Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., et al. (2007). A
genome-wide association study identifies novel risk loci for type 2 diabetes.
Nature 445, 881–885. doi: 10.1038/nature05616
Storey, J. D., and Tibshirani, R. (2003). Statistical significance for genomewide
studies. Proc. Natl. Acad. Sci. 100, 9440–9445. doi: 10.1073/pnas.1530509100
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette,
M. A., et al. (2005). Gene set enrichment analysis: a knowledge-based approach
for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U.S.A.
102, 15545–15550. doi: 10.1073/pnas.0506580102
van Dam, R. M. (2002). Dietary patterns and risk for type 2 diabetes mellitus in
u.s. men. Ann. Inter. Med. 136, 201. doi: 10.7326/0003-4819-136-3-200202050-
00008
Wang, K., Li, M., and Bucan, M. (2007). Pathway-based approaches for analysis
of genomewide association studies. Am. J. Hum. Genet. 81, 1278–1283. doi:
10.1086/522374
Wu, C., and Cui, Y. (2013). A novel method for identifying nonlinear gene-
environment interactions in case-control association studies. Hum. Genet. 132,
1413–1425. doi: 10.1007/s00439-013-1350-z
Wu, C., and Cui, Y. (2014). Boosting signals in gene-based association studies via
efficient snp selection. Brief. Bioinform. 15, 279–291. doi: 10.1093/bib/bbs087
Yu, K., Li, Q., Bergen, A. W., Pfeiffer, R. M., Rosenberg, P. S., Caporaso, N., et al.
(2009). Pathway analysis by adaptive combination of p-values.Genet. Epidemiol.
33, 700–709. doi: 10.1002/gepi.20422
Zaykin, D. V., Meng, Z., and Ehm, M. G. (2006). Contrasting linkage-
disequilibrium patterns between cases and controls as a novel
association-mapping method. Am. J. Hum. Genet. 78, 737–746. doi: 10.1086/
503710
Zaykin, D. V., Zhivotovsky, L. A., Westfall, P. H., and Weir, B. S. (2002). Truncated
product method for combining p-values. Genet. Epidemiol. 22, 170–185. doi:
10.1002/gepi.0042
Conflict of Interest Statement: The authors declare that the research was con-
ducted in the absence of any commercial or financial relationships that could be
construed as a potential conflict of interest.
Received: 19 August 2014; accepted: 27 October 2014; published online: 12 November
2014.
Citation: He T, Zhong P-S and Cui Y (2014) A set-based association test identifies sex-
specific gene sets associated with type 2 diabetes. Front. Genet. 5:395. doi: 10.3389/
fgene.2014.00395
This article was submitted to Statistical Genetics and Methodology, a section of the
journal Frontiers in Genetics.
Copyright © 2014 He, Zhong and Cui. This is an open-access article distributed under
the terms of the Creative Commons Attribution License (CC BY). The use, distribution
or reproduction in other forums is permitted, provided the original author(s) or licen-
sor are credited and that the original publication in this journal is cited, in accordance
with accepted academic practice. No use, distribution or reproduction is permitted
which does not comply with these terms.
Frontiers in Genetics | Statistical Genetics and Methodology November 2014 | Volume 5 | Article 395 | 8
